Skip to main content
. 2024 Dec 18;24:1551. doi: 10.1186/s12885-024-13309-z

Table 2.

Characteristics at baseline in each HRA group

0 HRA 1 HRA  ≥ 2 HRA p
n 215 113 43
Drug (%) 0.535
 PI plus IMiDs 116 (58.0) 58 (52.3) 22 (52.4)
 CD38-based 36 (18.0) 18 (16.2) 10 (23.8)
 PI or IMiDs 48 (24.0) 35 (31.5) 10 (23.8)
 Unknown 15 2 1
Sex (%) 0.011
 Female 74 (34.4) 48 (42.5) 25 (58.1)
 Male 141 (65.6) 65 (57.5) 18 (41.9)
Age 0.828
 ≥ 65 77 (35.8) 44 (38.9) 15 (34.9)
 < 65 138 (64.2) 69 (61.1) 28 (65.1)
MM Type 0.035
 IgA 38 (17.8) 33 (29.2) 9 (20.9)
 IgG 92 (43.0) 41 (36.3) 21 (48.8)
 IgD 7 (3.3) 13 (11.5) 3 (7.0)
 Light Chain Only 51 (23.8) 17 (15.0) 7 (16.3)
 Non-secretory 25 (11.7) 9 (8.0) 3 (7.0)
 Biclonal 1 (0.5) 0 (0.0) 0 (0.0)
 Unknown 1 0 0
ECOG Score (%) 0.745
 0–1 123 (57.2) 60 (53.1) 23 (53.5)
 ≥ 2 92 (42.8) 53 (46.9) 20 (46.5)
Transplantation (%) 0.857
 Yes 43 (21.5) 22 (19.8) 10 (23.8)
 No 157 (78.5) 89 (80.2) 32 (76.2)
 Unknown 15 (7.0) 2 (1.8) 1 (2.3)
ISS stage (%) 0.003
 1 70 (33.5) 24 (21.6) 5 (11.9)
 2 66 (31.6) 32 (28.8) 11 (26.2)
 3 73 (34.9) 55 (49.5) 26 (61.9)
 Unknown 6 2 1
RISS stage (%)  < 0.001
 1 67 (33.0) 18 (16.8) 0 (0.0)
 2 125 (61.6) 74 (69.2) 16 (38.1)
 3 11 (5.4) 15 (14.0) 26 (61.9)
 Unknown 12 6 1
BMPC%  < 0.001
 < 50% 178 (87.7) 83 (74.1) 26 (61.9)
 ≥ 50% 25 (12.3) 29 (25.9) 16 (38.1)
 Unknown 12 1 1
LDH (%) 0.2
 ≥ 250 26 (12.2) 20 (17.9) 9 (20.9)
 < 250 187 (87.8) 92 (82.1) 34 (79.1)
 Unknown 2 1 0
Cr (%) 0.171
 ≥ 177 32 (14.9) 23 (20.4) 11 (25.6)
 < 177 183 (85.1) 90 (79.6) 32 (74.4)
Ca (%) 0.002
 ≥ 2.75 17 (7.9) 10 (8.8) 11 (25.6)
 < 2.75 198 (92.1) 103 (91.2) 32 (74.4)
HGB (%)  < 0.001
 ≥ 100 136 (63.3) 48 (42.5) 12 (27.9)
 < 100 79 (36.7) 65 (57.5) 31 (72.1)

ECOG Score Eastern Cooperative Oncology Group Score; ISS stage International Staging System; RISS stage Revised International Staging System; BMPC% Bone marrow plasma cell percentage; LDH: Lactate dehydrogenase; Cr: Creatinine; Ca: Calcium; HGB Hemoglobin